ACEBROPHYLLINE 200mg. IP + FEXOFENADINE 120mg. IP + MONTELUKAST SODIUM 10mg. IP

A trio combination of mucolytic, antihistaminic, and a leukotriene receptor antagonist that addresses asthma, allergic rhinitis, chronic obstructive or asthma-like bronchitis. A promising therapeutic agent for treating allergy-mediated respiratory diseases. (Suzanne G Meeves, 2003) Attenuates the frequency and severity of episodic wheezing due to upper respiratory tract infections. (Bhattacharyya, 2020) Possesses anti-inflammatory properties that clears the inflammation of the lung airways. (Ajitha Sharma, 2014) Reduces the frequency of relapses of infection in bronchial obstruction. (Gangajalia, 2019) Effectively relieves the symptoms of seasonal allergies. (Kam Lun Ellis Hon, 2014) Eases itchy, watery, red eyes symptoms and nasal congestion of seasonal allergic rhinitis patients. (P Van Cauwenberge, 2000) Significantly decreases the amount of sputum and reduces airway obstruction. (Pozzi E., 2007) Loosens and breaks down the mucus by dilating the airway tubes, helping the patients to cough it up more easily. Stops the body’s reaction to histamines, and leukotrienes to reduce allergy symptoms and asthma. Provides relief from nasal congestion in patients with moderate to severe allergic rhinitis symptoms. Relieves congestion by opening up the airways and improves symptoms of allergies.